Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -45.29%6.69M | 16.68%8.39M | 141.17%9.52M | 242.50%47.91M | 607.21%24.55M | 425.33%12.22M | 71.70%7.19M | -4.39%3.95M | 115.50%13.99M | 43.27%3.47M |
| Selling and administrative expenses | -11.51%4.78M | 52.16%4.93M | 115.73%4.51M | 323.73%17.1M | 449.97%6.37M | 442.82%5.4M | 229.07%3.24M | 125.70%2.09M | 33.51%4.04M | 36.70%1.16M |
| -Selling and marketing expense | ---- | ---- | ---- | 143.04%1.28M | 100.13%212.24K | 241.33%479.62K | 111.47%335.11K | 165.81%328.84K | 110.45%524.65K | 213.83%106.05K |
| -General and administrative expense | -11.51%4.78M | 52.16%4.93M | 115.73%4.51M | 350.72%15.83M | 384.24%5.1M | 532.04%5.4M | 292.23%3.24M | 160.49%2.09M | 26.59%3.51M | 29.34%1.05M |
| Other operating expenses | -72.04%1.91M | -12.41%3.46M | 169.83%5.01M | 209.55%30.81M | 685.97%18.18M | 412.25%6.82M | 23.34%3.95M | -42.03%1.86M | 186.97%9.95M | 46.80%2.31M |
| Operating profit | 45.29%-6.69M | -16.68%-8.39M | -141.17%-9.52M | -242.50%-47.91M | -607.21%-24.55M | -425.33%-12.22M | -71.70%-7.19M | 4.39%-3.95M | -115.50%-13.99M | -43.27%-3.47M |
| Net non-operating interest income (expenses) | -92.81%80K | -94.75%18K | 155.20%319K | 490.63%2.34M | 696.81%761.85K | 816.09%1.11M | 153.94%343K | 160.06%125K | 162.48%396.5K | 139.74%95.61K |
| Non-operating interest income | -92.44%85K | -93.59%22K | 153.13%324K | 490.63%2.34M | 671.71%737.85K | 826.80%1.13M | 153.94%343K | 166.30%128K | 63.25%396.5K | -21.41%95.61K |
| Non-operating interest expense | -61.54%5K | --4K | 66.67%5K | ---- | ---- | --13K | --0 | --3K | ---- | ---- |
| Other net income (expenses) | 4,476.09%2.01M | -344.22%-6.03M | -37,709.76%-15.42M | 65.72%-1.65M | 93.97%-288.65K | -160.53%-46K | -2,848.05%-1.36M | 34.53%41K | -5,761.77%-4.82M | -6,107.03%-4.78M |
| Gain on sale of security | 6,825.85%3.19M | -239,255.07%-3.5M | -77,102.07%-15.97M | ---1.11M | ---1.08M | -168.29%-47.37K | 96.83%-1.46K | -31.95%20.74K | ---- | ---- |
| Special income (charges) | --0 | --0 | ---- | 73.11%-1.29M | 101.32%63.18K | --0 | ---1.36M | --34.31K | ---4.8M | ---4.8M |
| -Less:Restructuring and mergern&acquisition | --0 | --0 | ---- | --1.29M | ---63.18K | --0 | --1.36M | ---- | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --4.8M | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --34.31K | ---- | ---- |
| Other non-operating income (expenses) | -891.30%-456K | -59,200.00%-1.19M | 1,834.15%793K | 6,321.95%750.42K | --757.42K | ---46K | ---2K | --41K | ---12.06K | ---- |
| Income before tax | 58.82%-4.6M | -75.54%-14.4M | -551.15%-24.62M | -156.52%-47.22M | -195.11%-24.08M | -401.89%-11.16M | -100.19%-8.2M | 6.64%-3.78M | -155.37%-18.41M | -197.69%-8.16M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 58.82%-4.6M | -75.54%-14.4M | -551.15%-24.62M | -156.52%-47.22M | -195.11%-24.08M | -401.89%-11.16M | -100.19%-8.2M | 6.64%-3.78M | -155.37%-18.41M | -197.69%-8.16M |
| Net income continuous operations | 58.82%-4.6M | -75.54%-14.4M | -551.15%-24.62M | -156.52%-47.22M | -195.11%-24.08M | -401.89%-11.16M | -100.19%-8.2M | 6.64%-3.78M | -155.37%-18.41M | -197.69%-8.16M |
| Noncontrolling interests | -44K | -47K | 20K | -75.95K | -75.95K | 0 | 0 | 0 | 0 | |
| Net income attributable to the company | 59.21%-4.55M | -74.97%-14.35M | -551.68%-24.64M | -156.11%-47.14M | -194.18%-24M | -401.89%-11.16M | -100.19%-8.2M | 6.64%-3.78M | -155.37%-18.41M | -197.69%-8.16M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 59.21%-4.55M | -74.97%-14.35M | -551.68%-24.64M | -156.11%-47.14M | -194.18%-24M | -401.89%-11.16M | -100.19%-8.2M | 6.64%-3.78M | -155.37%-18.41M | -197.69%-8.16M |
| Diluted earnings per share | 75.00%-0.01 | -33.33%-0.04 | -250.00%-0.07 | -65.06%-0.1742 | -80.37%-0.0842 | -171.87%-0.04 | -32.52%-0.03 | 9.83%-0.02 | -59.14%-0.1055 | -108.02%-0.0467 |
| Basic earnings per share | 75.00%-0.01 | -33.33%-0.04 | -250.00%-0.07 | -65.06%-0.1742 | -80.37%-0.0842 | -171.87%-0.04 | -32.52%-0.03 | 9.83%-0.02 | -59.14%-0.1055 | -108.02%-0.0467 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.